Medical Decision Making in the Choice of a Thrombolytic Agent for Acute Myocardial Infarction

Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 1994 ,343.311-22 [Erratum. Lancet 1994 ;19;343.742]

The International Study Group In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin Lancet 1990,336 71-5 3. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group ISIS-3 a randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected myocardial infarction Lancet. 1992;339.753-70

The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 1993 ;329-673-82

Sleight P. Streptokinase is still the agent of choice for most patients with myocardial infarction Am J Therapeutics 1995 , 2.128-35

Hennekens CH , O'Donnell CJ , Ridker PM , Marder VJ Current issues concerning thrombolytic therapy for acute myocardial infarction J Am Coll Cardiol 1995;25:18S-22S

Naylor CD , Armstrong PW From thrombolytic megatrials to clinical policy-making: facing the facts Can J Cardiol. 1995, 11.472-6.

Brophy JM Interpreting results from thrombolytic megatrials distinguishing fact from fiction Can J Cardiol 1996, 12.89-92

Brophy JM , Joseph L. Placing trials in context using Bayesian analysis GUSTO revisited by Reverend Bayes. JAMA 1995, 273-871-5.

Lee KJ , Califf RM , Simes J. , Van der Werf F , Topol EJ Holding GUSTO up to the light Ann Intern Med. 1994,120 882-5

Cairns J. , Armstrong PW , Belenkie I. , et al. Canadian Consensus Conference on Coronary Thrombolysis—1994 update. Can J Cardiol 1994;10.517-29

Ryan TJ , Anderson JL , Antman EM , et al ACC/AHA guidelines for the management of acute myocardial infarction a report of the American College of Cardiology and the American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996,28 1328-428

Rouleau JL , Moye LA , Pfeffer MA , et al A comparison of management patterns after acute myocardial infarction in Canada and the United States The SAVE investigators N Engl J Med 1993,328.779-84

Pilote L. , Granger C. , Armstrong PW , Mark DB , Hlatky MA Differences in the treatment of myocardial infarction between the United States and Canada A survey of physicians in the GUSTO trial Med Care 1995,33.598-610

Mark DB , Naylor CD , Hlatky MA , et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 1994;331 1130-5.

Van de Werf F. , Topol EJ , Lee KL , et al. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries Results from the GUSTO trial Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries JAMA . 1995,273.1586-91

Tu JV , Naylor CD , Kumar D. , DeBuono BA , McNeil BJ , Hannan EL Coronary artery bypass graft surgery in Ontario and New York state which rate is right? Steering committee of the cardiac care network of Ontario Ann Intern Med. 1997; 126 13-9

Fisher ES , Wennberg JE , Stukel TA , Sharp SM Hospital readmission rates for cohorts of Medicare beneficiaries in Boston and New Haven N Engl J Med 1994;331 989-95

Pilote L. , Califf RM , Sapp S. , et al Regional variation across the United States in the management of acute myocardial infarction GUSTO-1 investigators Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries N Engl J Med 1995;333 565-72

Naylor CD , Jaglal SB Regional revascularization patterns after myocardial infarction in Ontario Can J Cardiol 1995;11: 670-4

Guadagnoli E. , Hauptman PJ , Ayanian JZ , Pashos CL , McNeil BJ , Cleary PD Variation in the use of cardiac procedures after acute myocardial infarction N Engl J Med 1995,333 573-8.

Ayanian JZ , Hauptman PJ , Guadagnoli E. , Antman EM , Pashos CL , McNeil BJ Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction N Engl J Med. 1994,331-1136-42

Jollis JG , DeLong ER , Peterson ED , et al Outcome of acute myocardial infarction according to the specialty of the admitting physician N Engl J Med. 1996 ;335:1880-7.

Kimmel SE , Berlin JA , Laskey WK The relationship between coronary angioplasty procedure volume and major complications JAMA 1995;274-1137-42.

Hannan EL , Kilburn H. , Bernard H. , O'Donnell JF , Lukacik G. , Shields EP Coronary artery bypass surgery. the relationship between inhospital mortality rate and surgical volume after controlling for clinical risk factors . Med Care 1991,29-1094-107

McLaughlin TJ , Soumerai SB , Willison DJ , et al Adherence to national guidelines for drug treatment of suspected acute myocardial infarction evidence for undertreatment in women and the elderly Arch Intern Med 1996 ;156.799-805 [Erratum. Arch Intern Med 1996;156 1920]

European Secondary Prevention Study Group Translation of clinical trials into practice a European population-based study of the use of thrombolysis for acute myocardial infarction Lancet 1996,347 1203-7

1995 Physician's GenRx 5th ed Riverside, CT Denniston Publishing, 1995 57-8,1784-6.

International joint efficacy comparison of thrombolytics Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (inject): trial to investigate equivalence. Lancet. 1995;346:329-36 [Erratum. Lancet 1995;346:980]

Brophy JM , Diodati JG , Bogaty P. , Théroux P. The delay to thrombolysis: an analysis of patient and hospital characteristics . Can Med Assoc J 1998;158-475-80.

Kass R. , Raftery AE Bayes factors. J Am Statistical Assoc. 1995 ; 90:773-95.

Gatsonis CA , Epstein AM , Newhouse JP , Normand SL , McNeil BJ Variations in the utilization of coronary angiography for elderly patients with an acute myocardial infarction. An analysis using hierarchical logistic regression. Med Care. 1995; 33:625-42.

Collins R. , Peto R. , Baigent C. , Sleight P. Drug therapy: aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction New Engl J Med 1997;336:847-59.

Brieger DB , Mak KH , White HD , et al. Benefit of early sustained reperfusion in patients with prior myocardial infarction (The GUSTO-1 trial). Am J Cardiol. 1998;81:282-7.

Califf RM , White HD , Van de Werf, et al. One year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-1) trial. Circulation. 1996; 94:1233-8

Mark DB , Hlatky MA , Califf RM , et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction [see comments]. N Engl J Med 1995;332:1418-24. [Erratum. N Engl J Med. 1995;333:267]

Braunwald E (ed). Heart Disease A Textbook of Cardiovascular Medicine. 5th ed Philadelphia, PA: WB Saunders , 1997: 1826.

Maynard C. , Litwin PE , Martin JS , Weaver WD Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 1992;152:972-6.

Ayanian JZ , Epstein AM Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 1991 ;325:221-5.

Le Conseil Consultatif de Pharmacologie. Gouvernement du Quebec. Thrombolytic therapy in myocardial infarction . Montreal, Quebec, Canada, February 1995.

Schull M. , Battista R. , Brophy JM , Joseph L. , Cass D. Appropriateness of coronary thrombolysis decision making by emergency physicians . Ann Emerg Med. 1998;31:12-8.

Gelman A. , Carlin JB , Stern HS , Rubin DB Bayesian Data Analysis. London, U.K.. Chapman and Hall, 1995.

Spiegelhalter D. , Thomas A. , Best N. , Gilks W. BUGS Bayesian inference using Gibbs sampling. BUGS Version 0.50, Copyright MRC Biostatistics Unit ( Http://Www.Mrc-Bsu.Cam.Ac.UkBugs/Mainpage.Html ), 1995.